187 related articles for article (PubMed ID: 2930692)
21. A retrospective analysis of different modalities for treatment of primary orbital non-Hodgkin's lymphomas.
Esik O; Ikeda H; Mukai K; Kaneko A
Radiother Oncol; 1996 Jan; 38(1):13-8. PubMed ID: 8850421
[TBL] [Abstract][Full Text] [Related]
22. Elderly patients with non-Hodgkin's lymphoma: population-based results in The Netherlands.
Maartense E; Hermans J; Kluin-Nelemans JC; Kluin PM; Van Deijk WA; Snijder S; Wijermans PW; Noordijk EM
Ann Oncol; 1998 Nov; 9(11):1219-27. PubMed ID: 9862053
[TBL] [Abstract][Full Text] [Related]
23. Combination chemotherapy for intermediate and high grade non-Hodgkin's lymphoma.
Dhaliwal HS; Rohatiner AZ; Gregory W; Richards MA; Johnson PW; Whelan JS; Gallagher CJ; Matthews J; Ganesan TS; Barnett MJ
Br J Cancer; 1993 Oct; 68(4):767-74. PubMed ID: 8398705
[TBL] [Abstract][Full Text] [Related]
24. [Treatment effect of DICE regimen on patients with relapsed or refractory intermediate and high grade non-Hodgkin's lymphoma].
Zhou SY; Shi YK; He XH; Zhang P; Dong M; Huang DZ; Yang JL; Zhang CG; Liu P; Yang S; Feng FY
Ai Zheng; 2005 Apr; 24(4):465-9. PubMed ID: 15820071
[TBL] [Abstract][Full Text] [Related]
25. [Non-Hodgkin's lymphomas. II. Analysis of the prognostic factors in a series of 307 patients].
García Zueco JC; Delgado MP; Giraldo MP; Perella M; Rubio-Félix D; Giralt M
Sangre (Barc); 1992 Oct; 37(5):337-44. PubMed ID: 1293772
[TBL] [Abstract][Full Text] [Related]
26. [Ki-67 proliferative index in non-Hodgkin's lymphoma and its clinical significance].
Li J; Hu R; Liao AJ; Shi HY; Yan W; Liu ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):935-9. PubMed ID: 21867618
[TBL] [Abstract][Full Text] [Related]
27. Low-grade lymphoma: clinical and prognostic studies in a series of 143 patients from a single institution.
Lopez-Guillermo A; Montserrat E; Bosch F; Escoda L; Terol MJ; Marin P; Reverter JC; Blade J; Cervantes F; Sierra J
Leuk Lymphoma; 1994 Sep; 15(1-2):159-65. PubMed ID: 7858494
[TBL] [Abstract][Full Text] [Related]
28. A controversial issue: could a watch-and-wait policy for patients with non-Hodgkin's lymphoma clinical stage I or IE with no lymphoma left following diagnostic surgery be justified? Results of a single centre study.
Jelić S; Frim O; Gligorijević G; Gavrilović D; Manojlović N; Jovanović V; Oprić M
Hematol Oncol; 1997 May; 15(2):53-61. PubMed ID: 9375030
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors and survival in non-Hodgkin's lymphomas: the experience of the Istituto Oncologico Romagnolo (IOR).
Pasquini E; Nicolini M; Rosti G; Amadori M; Pileri S; Nanni O; Fattori PP; Marangolo M; Amadori D; Ravaioli A
Leuk Lymphoma; 1994 Aug; 14(5-6):475-82. PubMed ID: 7812208
[TBL] [Abstract][Full Text] [Related]
30. Prognostic markers in malignant lymphoma: an analysis of 1,198 patients treated at a single centre.
Low SE; Horsman JM; Hancock H; Walters SJ; Hancock BW
Int J Oncol; 2001 Dec; 19(6):1203-9. PubMed ID: 11713590
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposide.
Wheeler C; Strawderman M; Ayash L; Churchill WH; Bierer BE; Elias A; Gilliland DG; Antman K; Guinan EC; Eder JP
J Clin Oncol; 1993 Jun; 11(6):1085-91. PubMed ID: 8099120
[TBL] [Abstract][Full Text] [Related]
32. [Detection of soluble interleukin-2 receptor in the serum of patients with non-Hodgkin's lymphoma].
Pérez Encinas M; Bello JL; Bendaña A; Rabuñal MJ; González S; Abuín I; Noya M; Cadarso C
Med Clin (Barc); 1998 Jul; 111(5):161-7. PubMed ID: 9732831
[TBL] [Abstract][Full Text] [Related]
33. Age-related prognostic factor analysis in non-Hodgkin's lymphoma.
Maksymiuk AW; Haines C; Tan LK; Skinnider LF
Can J Oncol; 1996 Jun; 6(1):435-42. PubMed ID: 8853516
[TBL] [Abstract][Full Text] [Related]
34. Beta-2 microglobulin: a prognostic factor in diffuse aggressive non-Hodgkin's lymphomas.
Johnson PW; Whelan J; Longhurst S; Stepniewska K; Matthews J; Amess J; Norton A; Rohatiner AZ; Lister TA
Br J Cancer; 1993 Apr; 67(4):792-7. PubMed ID: 8471438
[TBL] [Abstract][Full Text] [Related]
35. Chemotherapy of intermediate- and high-grade non-Hodgkin's lymphomas with a high-dose doxorubicin-containing regimen.
Zuckerman KS; LoBuglio AF; Reeves JA
J Clin Oncol; 1990 Feb; 8(2):248-56. PubMed ID: 2299368
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors in patients who received autologous bone marrow transplantation for non-Hodgkin's lymphoma. Report of 104 patients from the Spanish Cooperative Group GEL/TAMO.
Conde E; Sierra J; Iriondo A; Domingo A; García Laraña J; Marín J; Caballero D; Martínez F; León A; García-Conde J
Bone Marrow Transplant; 1994 Aug; 14(2):279-86. PubMed ID: 7994243
[TBL] [Abstract][Full Text] [Related]
37. Primary extranodal non-Hodgkin's lymphoma in adults: clinicopathological and survival characteristics.
Economopoulos T; Asprou N; Stathakis N; Papageorgiou E; Dervenoulas J; Xanthaki K; Raptis S
Leuk Lymphoma; 1996 Mar; 21(1-2):131-6. PubMed ID: 8907280
[TBL] [Abstract][Full Text] [Related]
38. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx].
Yuan ZY; Li YX; Zhao LJ; Gao YH; Liu XF; Gu DZ; Qian TN; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):425-9. PubMed ID: 15355649
[TBL] [Abstract][Full Text] [Related]
39. Durability of remission after ABMT for NHL: the importance of the 2-year evaluation point.
Bolwell B; Goormastic M; Andresen S
Bone Marrow Transplant; 1997 Mar; 19(5):443-8. PubMed ID: 9052909
[TBL] [Abstract][Full Text] [Related]
40. The treatment of elderly patients with aggressive non-Hodgkin's lymphomas: feasibility and efficacy of an intensive multidrug regimen.
Bertini M; Freilone R; Vitolo U; Botto B; Ciotti R; Cinieri S; Di Nota A; Di Vito F; Levis A; Orsucci L; Pini M; Rota-Scalabrini D; Todeschini G; Resegotti L
Leuk Lymphoma; 1996 Aug; 22(5-6):483-93. PubMed ID: 8882962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
